Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Department of Infectious Diseases, Peking University First Hospital, Beijing, China.
Front Immunol. 2023 Jan 5;13:1113070. doi: 10.3389/fimmu.2022.1113070. eCollection 2022.
Study of clinical characteristics of hepatitis B virus deoxyribonucleic acid (HBV DNA)-negative, hepatitis B surface antigen (HBsAg)-positive, hepatitis B e antigen (HBeAg)-negative patients based on liver histopathology.
We retrospectively enrolled patients with chronic HBV infection diagnosis at Beijing Ditan Hospital from May 2008 to November 2020. To study the differences between patients with significant hepatic histopathology and those without significant hepatic histopathology. And to study the independent factors of significant hepatic histopathology.
85 HBV DNA-negative and HBeAg-negative patients were 37.90 ± 10.30 years old, 23.50% of patients with grade of inflammation (G) >1, 35.30% of patients with liver fibrosis stage (S) >1, 44.70% patients were diagnosed with significant hepatic histopathology. Compared to the no significant hepatic histopathology group, another group had older age (41.70 ± 10.70 vs 34.80 ± 8.87 years, t=-3.28, =0.002), higher total bilirubin (TBIL) [14.9(10.3, 22.4) vs 11(8.9, 14.4) μmol/L, z=-2.26, =0.024], lower cholinesterase (CHE) (t=-2.86, =0.005, 7388.00 ± 2156.00 vs 8988.00 ± 2823.00 U/L) and lower platelet (PLT) (t=2.75, =0.007, 157.00 ± 61.40 vs 194.00 ± 61.00 10^9/L). Abnormal ALT patients are more likely to have significant hepatic histopathology (z=5.44, =0.020, 66.70% vs 337.50%). G had significant correlation with CHE (=0.008, r=-0.23), alanine aminotransferase (ALT) (=0.041, r=0.18), aspartate aminotransferase (AST) (=0.001, r=0.29). S had significant correlation with TBIL ( = 0.008, r = 0.23), age ( < 0.001, r = 0.32), international normalized ratio (INR) ( = 0.04, r = 0.23), CHE ( < 0.001, r = -0.30), PLT ( < 0.001, r = -0.40) and prothrombin time activity (PTA) ( = 0.046, r = -0.22). Multivariate logistic analysis indicated only age (95%CI=1.014~1.130, OR=1.069, =0.013) was an impact factor for significant hepatic histopathology. The cutoff point of age was 34.30 years.
A large proportion of chronic HBV infection patients with HBeAg-negative and HBV DNA-negative still have chronic hepatitis. Age is an independent factor for significant hepatic histopathology.
基于肝组织病理学研究乙型肝炎病毒脱氧核糖核酸(HBV DNA)阴性、乙型肝炎表面抗原(HBsAg)阳性、乙型肝炎 e 抗原(HBeAg)阴性患者的临床特征。
我们回顾性纳入了 2008 年 5 月至 2020 年 11 月在北京地坛医院诊断为慢性乙型肝炎病毒感染的患者。研究有显著肝组织病理学和无显著肝组织病理学患者之间的差异,并研究显著肝组织病理学的独立因素。
85 例 HBV DNA 阴性和 HBeAg 阴性患者的年龄为 37.90±10.30 岁,23.50%的患者炎症分级(G)>1,35.30%的患者肝纤维化分期(S)>1,44.70%的患者诊断为显著肝组织病理学。与无显著肝组织病理学组相比,另一组年龄更大(41.70±10.70 岁 vs 34.80±8.87 岁,t=-3.28,=0.002),总胆红素(TBIL)更高[14.9(10.3,22.4)μmol/L vs 11(8.9,14.4)μmol/L,z=-2.26,=0.024],胆碱酯酶(CHE)更低(t=-2.86,=0.005,7388.00±2156.00 U/L vs 8988.00±2823.00 U/L),血小板(PLT)更低(t=2.75,=0.007,157.00±61.40 10^9/L vs 194.00±61.00 10^9/L)。异常 ALT 患者更有可能出现显著肝组织病理学(z=5.44,=0.020,66.70% vs 337.50%)。G 与 CHE(=0.008,r=-0.23)、丙氨酸氨基转移酶(ALT)(=0.041,r=0.18)、天冬氨酸氨基转移酶(AST)(=0.001,r=0.29)有显著相关性。S 与 TBIL(=0.008,r=0.23)、年龄(<0.001,r=0.32)、国际标准化比值(INR)(=0.04,r=0.23)、CHE(<0.001,r=-0.30)、PLT(<0.001,r=-0.40)和凝血酶原时间活动度(PTA)(=0.046,r=-0.22)有显著相关性。多因素 logistic 分析表明,只有年龄(95%CI=1.014~1.130,OR=1.069,=0.013)是显著肝组织病理学的影响因素。年龄的截断点为 34.30 岁。
相当一部分 HBeAg 阴性和 HBV DNA 阴性的慢性乙型肝炎病毒感染患者仍患有慢性肝炎。年龄是显著肝组织病理学的独立因素。